MedTrace Logo

Letrozole Step-up Protocol for Ovulation Induction in Infertile Women With PCOS

NCT03181919 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2017-06-09

No results posted yet for this study

Summary

the aim of the study is to compare between the step-up and conventional protocols in ovulation induction in infertile women with PCOS

Conditions

  • Infertility Poly Cystic Ovary

Interventions

DRUG

Letrozole

Letrozole is a third generation inhibitor that is emerging as a new oral agent for induction of ovulation.

Sponsors & Collaborators

  • Benha University

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
35 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-01
Primary Completion
2017-01-01
Completion
2017-03-01

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03181919 on ClinicalTrials.gov